SMOORE International Reports 2022 Financial Performance

Mar.21.2023
SMOORE International Reports 2022 Financial Performance
Smoore International's 2022 performance report indicates an 11.7% decline in revenue and a 52.7% decrease in net profit.

On March 20th, Semiconductor Manufacturing International Corporation (SMIC) released its 2022 financial performance report. The report revealed that SMIC had a revenue of 12.145 billion yuan in 2022, a decrease of 11.7% from the previous year. After adjustments, their net profit for the year was 2.575 billion yuan, a decrease of 52.7% from the previous year.


Summary of SMIC's Financial Report | Source: SMIC Financial Report


More than 80% of overseas revenue: Decline in the US, Rise in Europe. According to the financial report, Smore's total revenue for 2022 was CNY 12.145 billion, with an export income of CNY 9.898 billion accounting for 81.5% of the total revenue, an increase of 15.5% compared to last year. Domestic sales revenue was CNY 2.246 billion, accounting for 18.5% of the total revenue, a decrease of 15.5% compared to last year.


Market Revenue in Simoer | Source: Simoer Financial Report


In 2022, Smoore's sales revenue for enterprise customers in the United States decreased by 22.7% due to increased competition from non-compliant electronic cigarette products and price adjustments for certain products to support some clients in gaining market share. This decline was analyzed by region.


In the financial report, Somor expressed confidence in the future competitiveness of its products and long-term growth in the US market, as the FDA continues to strengthen its enforcement efforts.


In Europe and other markets, Smoore's sales revenue in 2022 increased by 53.4% compared to the previous year. Smoore stated in their financial report that they have assisted major clients in becoming the top electronic cigarette brand in several European countries.


In China, Synergy, a company that specializes in providing marketing solutions, saw a 51.9% year-on-year decrease in sales revenue specifically to enterprise customers. This has had a significant negative impact on Synergy's overall revenue.


Business Type Revenue for SMIC | Source: SMIC Financial Report


The revenue of the company's disposable electronic cigarette products was 1.9 billion yuan, over 19 times higher than the previous year.


According to the financial report, Smoore recently launched a new line of disposable e-cigarettes in the European market, leading to a rapid increase in sales. In 2022, the revenue from disposable products amounted to 1.93 billion yuan, representing a growth of 1919% compared to the 0.95 billion yuan in 2021. Notably, the revenue from the second half of the year reached 1.61 billion yuan, reflecting a year-over-year increase of 1761%.


In addition, in the second half of 2022, Simoer upgraded their open system product LUXE X, further increasing their market share.


According to the financial report, in 2022, Simoer's revenue from sales of products to retail customers was 1.465 billion yuan, a year-on-year increase of 26.2%.


Research and development investment doubled, enhancing the competitiveness of core brands.


According to the financial report, in 2022, Smoore invested 1.372 billion yuan in research and development, an increase of 104% compared to the previous year. Of this, 74% was spent on electronic nicotine delivery systems (including electronic vaporization and non-combustible heating products), 13.9% on specialty vaporization products, and 12.1% on vaporization medical and beauty products.


Silmor R&D expenses | Source: Silmor financial report


According to financial reports, in 2022, Smor added 2,254 patents, including 1,125 invention patents.


In terms of brand building, SMOORE has announced that it will continue to focus on its manufacturing brand "SMOORE" and create three distinct technology brands: FEELM representing closed-system vaping products, METEX representing non-combustible heating products, and VAPORESSO representing open-system vaping products.


According to SiMoEr, in the future, they plan to launch new products with differentiation in the fields of electronic cigarette devices, specialized nebulization products, and nebulized medicine, expanding the scope of nebulization technology applications.


Reference:


As of December 31st, 2022, the annual performance report for Sumo International Holdings Limited has been announced.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy
83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy
Eighty-three international experts in public health and tobacco control have co-signed a letter to the European Commission warning that the forthcoming revision of the Tobacco Excise Directive could seriously harm public health if it imposes high taxes on lower-risk alternatives such as e-cigarettes, heated tobacco, and nicotine pouches. The experts argue that the EU’s stance that “non-combustible nicotine products carry risks comparable to cigarettes” contradicts scientific evidence.
Sep.02 by 2FIRSTS.ai
China Tobacco Hunan IC × Firstunion Group: Usonic Dual Wins International Award with Omni-directional Thermal Technology
China Tobacco Hunan IC × Firstunion Group: Usonic Dual Wins International Award with Omni-directional Thermal Technology
On September 18 at InterTabac 2025, China Tobacco Hunan IC launched the Usonic Dual, NISE, winning the "Best HNB Product Award." Featuring innovative "Omni-directional Vortex Thermal Field" technology and AI interaction, it enhances flavor, efficiency, and user experience, marking a significant advancement in global HTP development driven by Chinese innovation.
Sep.20
Premiere of the Cigar Culture Summit at InterTabac 2025: Be there!
Premiere of the Cigar Culture Summit at InterTabac 2025: Be there!
This year, the 45th InterTabac will provide the setting for a premiere aimed at one of the trade show’s most important target groups. Together with its new partner, The Cigar Academy from the USA, Messe Dortmund is hosting the Cigar Culture Summit on September 17 – one day before the start of the show. This exclusive summit will unite the leading figures in the cigar world: from legendary manufacturers and growers to influential media, importers and retailers.
Sep.15
新闻标题:Cigar Sense启动新研究:雪茄消费者期待与实际体验的关联
新闻标题:Cigar Sense启动新研究:雪茄消费者期待与实际体验的关联
Carson City, Nevada, Sept 19, 2025—A new study by Cigar Sense Inc. explores the impact of consumer expectations on cigar experiences.
Sep.23 by 2FIRSTS.ai
Texas e-cigarette shop owner arrested for allegedly hiding an unfinished tunnel inside his shop, possibly linked to international smuggling
Texas e-cigarette shop owner arrested for allegedly hiding an unfinished tunnel inside his shop, possibly linked to international smuggling
During a raid by federal and local law enforcement officers at an e-cigarette shop in Laredo, Texas, a 25-foot-deep tunnel, possibly linked to a transnational criminal organization, was discovered. The shop's owner, Gilberto Pena, was arrested for possession of controlled substances. Cocaine and marijuana were also seized during the raid. A total of 22 e-cigarette shops were inspected in Laredo, resulting in one arrest. The shop in question remains open, but the tunnel will be removed.
Sep.24 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21